Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-44
Closed -$3.42K 1390
2024
Q4
$3.42K Hold
44
﹤0.01% 1072
2024
Q3
$2.95K Hold
44
﹤0.01% 1060
2024
Q2
$4.99K Hold
44
﹤0.01% 955
2024
Q1
$6.1K Hold
44
﹤0.01% 888
2023
Q4
$5.46K Hold
44
﹤0.01% 898
2023
Q3
$4.11K Hold
44
﹤0.01% 971
2023
Q2
$5.65K Buy
+44
New +$5.32K ﹤0.01% 890

Other funds holding DXCM

Key Financial Inc's DXCM Position: Q1 2025 in Review

Key Financial Inc sold out of DexCom (DXCM) in Q1 2025, closing a stake of 44 shares — an estimated $3.42K sold.

Key Financial Inc first reported a position in DXCM in Q2 2023 and held it in 7 quarters. The position peaked at $6.1K in Q1 2024. 932 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • Key Financial Inc reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
  • Key Financial Inc sold 44 DexCom shares in Q1 2025, an estimated $3.42K.
  • Key Financial Inc first reported a position in DexCom in Q2 2023 and held it in 7 quarters.
  • Key Financial Inc's DexCom position peaked at $6.1K in Q1 2024.
  • 932 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Key Financial Inc's 13F filing for Q1 2025, filed 1 May 2025.